Sovaldi and Immunocomplex mediated hypersensitivity - a phase IV clinical study of FDA data

Summary:

We study 12,844 people who take Sovaldi (sofosbuvir) or have Immunocomplex mediated hypersensitivity. No report of Immunocomplex mediated hypersensitivity is found in people who take Sovaldi.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Sovaldi?

Sovaldi has active ingredients of sofosbuvir. eHealthMe is studying from 12,697 Sovaldi users. Check the latest studies of Sovaldi.

What is Immunocomplex Mediated Hypersensitivity?

Immunocomplex mediated hypersensitivity (abnormal or pathologic immune reaction that is caused by an immune response to repeated exposure to an antigen) is found to be associated with 14 drugs and 27 conditions by eHealthMe. Check the latest studies of Immunocomplex mediated hypersensitivity.

On Apr, 15, 2026

No report is found.

Do you take Sovaldi and have Immunocomplex mediated hypersensitivity?

- Check whether Immunocomplex mediated hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sovaldi:

Sovaldi (12,697 reports)

Immunocomplex mediated hypersensitivity treatments and more:

Immunocomplex mediated hypersensitivity (147 reports)

How severe was Immunocomplex mediated hypersensitivity and when was it recovered:

Immunocomplex mediated hypersensitivity in Sovaldi

Expand to all the drugs that have ingredients of sofosbuvir:

Immunocomplex mediated hypersensitivity and drugs with ingredients of sofosbuvir

Browse all side effects of Sovaldi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Immunocomplex mediated hypersensitivity:

Immunocomplex mediated hypersensitivity

Browse all the conditions that are associated with Immunocomplex mediated hypersensitivity:

Immunocomplex mediated hypersensitivity

How the study uses the data?

The study uses data from the FDA. It is based on sofosbuvir (the active ingredients of Sovaldi) and Sovaldi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.